Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus

INTRODUCTION: Sodium-dependent glucose transporter-2 (SGLT2) inhibitors such as dapagliflozin induce weight loss, but the mechanism is thought to involve loss of both body fat and skeletal muscle mass. The decrease in skeletal muscle mass may lead to worsening of insulin resistance in type 2 diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Yasuhiro, Kuribayashi, Nobuichi, Uchida, Daigaku, Suzuki, Daisuke, Kato, Mitsutoshi, Nagayama, Daiji, Ohashi, Hiroshi, Ohira, Masahiro, Saiki, Atsuhito, Tatsuno, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349273/
https://www.ncbi.nlm.nih.gov/pubmed/30574667
http://dx.doi.org/10.1007/s13300-018-0555-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349273/
https://www.ncbi.nlm.nih.gov/pubmed/30574667
http://dx.doi.org/10.1007/s13300-018-0555-5

Ejemplares similares